148 related articles for article (PubMed ID: 7994650)
21. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
Baroggi N; Etienne A; Braquet P
Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
[TBL] [Abstract][Full Text] [Related]
22. Action of platelet-activating factor (PAF) antagonists on the bronchopulmonary effects of PAF in the guinea-pig.
Pons F; Touvay C; Lejeune V; Carré C; Vilain B; Broquet C; Mencia-Huerta JM; Braquet P
J Lipid Mediat; 1989; 1(6):329-40. PubMed ID: 2519901
[TBL] [Abstract][Full Text] [Related]
23. IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor.
Breviario F; Bertocchi F; Dejana E; Bussolino F
J Immunol; 1988 Nov; 141(10):3391-7. PubMed ID: 3263425
[TBL] [Abstract][Full Text] [Related]
24. Effects of PAF antagonist, BN52021, on the PAF-, methacholine-, and allergen-induced bronchoconstriction in asthmatic children.
Hsieh KH
Chest; 1991 Apr; 99(4):877-82. PubMed ID: 2009789
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary hypertension and edema induced by platelet-activating factor in isolated, perfused rat lungs are blocked by BN52021.
Imai T; Vercellotti GM; Moldow CF; Jacob HS; Weir EK
J Lab Clin Med; 1988 Feb; 111(2):211-7. PubMed ID: 3339274
[TBL] [Abstract][Full Text] [Related]
26. Effect of the platelet activating factor antagonist BN52021 in rabbits: role in gentamicin nephrotoxicity.
Hanslik T; Blanchet F; Nochy D; Pirotzky E; Guilmard C; Seta N; Carbon C
Toxicol Appl Pharmacol; 1994 Sep; 128(1):111-5. PubMed ID: 8079343
[TBL] [Abstract][Full Text] [Related]
27. [Effect of ginkgolide B on platelet-activating factor induced activation of rat polymorphonuclear leukocytes].
Nie ZG; Wang WJ
Yao Xue Xue Bao; 2003 Feb; 38(2):98-102. PubMed ID: 12778742
[TBL] [Abstract][Full Text] [Related]
28. PAF-like activity of O-acetylated sphingomyelin.
Berdyshev EV; Getmanova OE
Biomed Sci; 1991; 2(5):485-8. PubMed ID: 1840837
[TBL] [Abstract][Full Text] [Related]
29. Effect of platelet activating factor antagonists on cultured rat mesangial cells.
Neuwirth R; Singhal P; Satriano JA; Braquet P; Schlondorff D
J Pharmacol Exp Ther; 1987 Nov; 243(2):409-14. PubMed ID: 3119816
[TBL] [Abstract][Full Text] [Related]
30. The effects of PAF antagonists on ischaemia and reperfusion arrhythmias and ischaemia-induced platelet aggregation.
Wainwright CL; Parratt JR; Bigaud M
Biomed Biochim Acta; 1988; 47(10-11):S224-7. PubMed ID: 3248108
[TBL] [Abstract][Full Text] [Related]
31. Cooperation between tumor necrosis factor (TNF) and platelet-activating factor (PAF) in the inflammatory response.
Maestre C; Zarco P; Gómez-Guerrero C; González E; Herrero-Beaumont G; Braquet M; Egido J
J Lipid Mediat; 1990; 2 Suppl():S151-9. PubMed ID: 1966813
[TBL] [Abstract][Full Text] [Related]
32. The effect of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulation.
Coyle AJ; Urwin SC; Page CP; Touvay C; Villain B; Braquet P
Eur J Pharmacol; 1988 Mar; 148(1):51-8. PubMed ID: 3383997
[TBL] [Abstract][Full Text] [Related]
33. Antagonist of platelet-activating factor prevents prostaglandin E2 induced ocular hypertension in rabbits.
Jager GV; van Delft JL; van Haeringen NJ; Verbeij NL; Braquet P
Prostaglandins; 1993 Jan; 45(1):97-105. PubMed ID: 8424134
[TBL] [Abstract][Full Text] [Related]
34. Platelet activating factor antagonists interact with GABAA receptors.
Miller LG; Bazan NG; Roy RB; Clostre F; Gaver A; Braquet P
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):253-6. PubMed ID: 1667341
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of PAF-induced platelet aggregation in man.
Küster LJ; Filep J; Frölich JC
Thromb Res; 1986 Aug; 43(4):425-33. PubMed ID: 3764802
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of PAF antagonists using human neutrophils in a microtiter plate assay.
Dewald B; Baggiolini M
Biochem Pharmacol; 1987 Aug; 36(15):2505-10. PubMed ID: 3649232
[TBL] [Abstract][Full Text] [Related]
37. Separate induction of human blood platelet aggregation or cytotoxicity by different concentrations of PAF-acether and thrombin.
Tran A; Vanhée D; Capron A; Vorng H; Braquet P; Joseph M
Agents Actions; 1992 May; 36(1-2):39-43. PubMed ID: 1414687
[TBL] [Abstract][Full Text] [Related]
38. Cellular electrophysiological effects of platelet-activating factor (PAF) and its antagonist BN 52021 in cardiac preparations.
Kecskemeti V; Braquet P
Drugs Exp Clin Res; 1992; 18(1):9-16. PubMed ID: 1600866
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity.
Etienne A; Hecquet F; Guilmard C; Soulard C; Braquet P
Int J Tissue React; 1987; 9(1):19-26. PubMed ID: 3596954
[TBL] [Abstract][Full Text] [Related]
40. Influence of platelet activating factor antagonists on the protamine sulphate stimulated release of histamine from peritoneal mast cells of rats in vitro.
Lohde C; Bahr T; Labes D; Grupe R
Arzneimittelforschung; 1992 Jan; 42(1):27-31. PubMed ID: 1375025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
